These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23165628)

  • 1. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
    Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
    Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
    Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
    Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRIG and cancer prognosis.
    Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
    Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.
    Lindström AK; Hellberg D
    Eur J Histochem; 2014 Apr; 58(2):2227. PubMed ID: 24998916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
    Holmlund C; Haapasalo H; Yi W; Raheem O; Brännström T; Bragge H; Henriksson R; Hedman H
    Neuropathology; 2009 Jun; 29(3):242-7. PubMed ID: 18992012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.
    Ranhem C; Lillsunde Larsson G; Hedman H; Lindquist D; Karlsson MG; Hellström AC; Östensson E; Sorbe B; Hellman K; Andersson S
    PLoS One; 2017; 12(8):e0183816. PubMed ID: 28841699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
    Wu X; Hedman H; Bergqvist M; Bergström S; Henriksson R; Gullbo J; Lennartsson J; Hesselius P; Ekman S
    Acta Oncol; 2012 Jan; 51(1):69-76. PubMed ID: 21417672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
    Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
    Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.
    Ghasimi S; Haapasalo H; Eray M; Korhonen K; Brännström T; Hedman H; Andersson U
    J Neurooncol; 2012 Jul; 108(3):435-41. PubMed ID: 22484910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer.
    Lindquist D; Näsman A; Tarján M; Henriksson R; Tot T; Dalianis T; Hedman H
    Br J Cancer; 2014 Apr; 110(7):1793-800. PubMed ID: 24548859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.
    Malik U; Javed A
    Curr Cancer Drug Targets; 2017; 17(1):3-16. PubMed ID: 27628597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
    Del Rio T; Nishitani AM; Yu WM; Goodrich LV
    PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
    Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
    Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
    Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
    J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.